World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
15075
World Ranking
4386
National Ranking
1990

Hillel S. Panitch publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hillel S. Panitch sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 118 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hillel S. Panitch D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hillel S. Panitch sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hillel S. Panitch was affiliated with the University of Vermont in the United States during their academic career. Their work focused primarily on research within the university setting until their passing.

Information regarding their research fields, publication history, and collaborative efforts is limited. No specific data on recent papers, including titles, publication years, or venues, has been documented. Likewise, there is no record of frequent coauthors or commonly featured publication venues associated with their work.

No topics, subfields, or main fields of study have been provided, leaving the precise academic focus areas unreported. Similarly, there are no entries cataloging book publications or awards received during their career.

Due to the absence of details on their specific contributions or recognitions, the profile remains highly concise and limited to their institutional affiliation and status as deceased.

Best Publications

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Treatment of multiple sclerosis with gamma interferon

    Unknown

  • Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

    Mark Keegan;Fatima König;Robyn McClelland;Wolfgang Brück

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • Systemic recombinant human interferon-β treatment of relapsing-remitting multiple sclerosis : pilot study analysis and six-year follow-up

    R.L. Knobler;J.I. Greenstein;K.P. Johnson;F.D. Lublin

  • Plasmapheresis in multiple sclerosis: Preliminary findings

    Peter C. Dau;Jack H. Petajan;Kenneth P. Johnson;Hillel S. Panitch

  • Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro

    Unknown

  • Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

    Jerome J. Graber;David Ford;Min Zhan;Gordon Francis

  • Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein

    Ron Milo;Hillel Panitch

  • Glatiramer acetate blocks the activation of THP-1 cells by interferon-γ

    Qingdi Li;Ron Milo;Ron Milo;Hillel Panitch;Hillel Panitch;Peggy Swoveland;Peggy Swoveland

  • Subacute sclerosing panencephalitis: remission after treatment withintraventricular interferon

    Unknown

  • Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by concanavalin a and myelin basic protein

    Hillel S. Panitch;Hillel S. Panitch

  • Interferon-β-1a induces increases in vascular cell adhesion molecule: Implications for its mode of action in multiple sclerosis

    J. Graber;M. Zhan;D. Ford;F. Kursch

  • Recurrent herpes simplex encephalitis: Recovery of virus after Ara-A treatment

    Dix Rd;Baringer;Panitch Hs;Rosenberg Sh

  • Immunological studies of scrapie infection

    Kenneth C. Kasper;Daniel P. Stites;Karen A. Bowman;Hillel Panitch

  • Gamma-interferon induction in patients with chronic progressive MS.

    C. T. Bever;H. S. Panitch;H. B. Levy;D. E. McFarlin

  • Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon.

    Hillel S. Panitch;Hillel S. Panitch;Hillel S. Panitch;Gordon S. Francis;Gordon S. Francis;Carol J. Hooper;Carol J. Hooper;Thomas C. Merigan;Thomas C. Merigan

  • Adoptive transfer of experimental allergic encephalomyelitis: Requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein

    Hillel S. Panitch;Hillel S. Panitch;Carlo Ciccone;Carlo Ciccone

  • Clinical trial of natural alpha interferon in multiple sclerosis.

    Robert L. Knobler;Hillel S. Panitch;Sherry L. Braheny;Jack C. Sipe

  • Use of aggregating brain cultures to study the replication of herpes simplex virus types 1 and 2 in central nervous system tissue

    L Pulliam;R D Dix;H S Panitch;J R Baringer

  • T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis

    Robert L. Hirsch;Jose Ordonez;Hillel S. Panitch;Hillel S. Panitch;Kenneth P. Johnson;Kenneth P. Johnson

  • Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?:

    Bar-Or A;Oger J;Gibbs E;Niino M

  • Decreased interferon synthesis and responsiveness to interferon by leukocytes from multiple sclerosis patients given natural alpha interferon.

    Roberta M. Kamin-Lewis;Hillel S. Panitch;Thomas C. Merigan;Kenneth P. Johnson

  • Antibodies to Myelin Basic Protein in Cerebrospinal Fluid of Patients with Multiple Sclerosis

    H. S. Panitch;D. A. Hafler;K. P. Johnson

  • Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.

    L Pulliam;H S Panitch;J R Baringer;R D Dix

  • Leukocytes from multiple sclerosis patients respond to α- and γ-interferons

    Roberta M. Kamin-Lewis;Roberta M. Kamin-Lewis;Hillel S. Panitch;Hillel S. Panitch;Kenneth P. Johnson;Kenneth P. Johnson

Frequent Co-Authors

Thomas C. Merigan
Thomas C. Merigan Stanford University
Michael J. Aminoff
Michael J. Aminoff University of California, San Francisco
David A. Hafler
David A. Hafler Yale University
Michael B. A. Oldstone
Michael B. A. Oldstone Scripps Research Institute
Howard L. Weiner
Howard L. Weiner Harvard University
David Norman
David Norman University of California, San Francisco
Robert A. Kyle
Robert A. Kyle Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which benefit from advanced nursing qualifications. For those aiming to enhance their clinical expertise, exploring an accelerated nurse practitioner programs can be a strategic move, especially for individuals transitioning from a nursing background. These programs offer a fast track to specialized roles that integrate immunology with patient care.

Nurses interested in specialized acute care may consider obtaining an acute care certification for FNP. This certification equips Family Nurse Practitioners with the skills necessary to manage critically ill patients, blending immunology knowledge with acute clinical interventions.

For those new to nursing, enrolling in online ADN programs for non nurses offers an accessible pathway into the field. These degrees build foundational skills that support further specialization, including roles related to immunological health and disease management.

Career planning should also consider financial rewards. Understanding the dnp salary by specialty helps prospective students gauge the economic benefits of pursuing a Doctor of Nursing Practice in immunology-related fields. This insight supports informed decisions about education and career trajectories.

Best Scientists Citing Hillel S. Panitch

Recently Published Articles